MD

MdxHealth SA (MDXH)

NASDAQ

Currency in USD
0.7888
+0.05 (+6.45%)

Closed

Aug 25, 2026

Day's Range

0.7266
0.7998

52 wk Range

0.4000
5.33

Overview - MDXH - MdxHealth SA

Key Statistics

Valuation

Enterprise Value

125.59M

P/E (Trailing)

‪-1.17‬

P/E (Forward)

‪-2.02‬

PEG Ratio

‪0.11‬

Price / Sales (TTM)

‪0.64‬

Price / Book

‪-2.03‬

EV / EBITDA

‪-8.41‬

Profitability

Gross Margin

‪60.66%‬

Profit Margin

‪-32.74%‬

Operating Margin

‪-18.74%‬

Return on Assets

‪-9.83%‬

Return on Equity

‪277.15%‬

Ownership

Shares Outstanding

51.36M

Float

43.38M

Short % of Shares Outstanding

‪2.74%‬

Held by Insiders

‪22.14%‬

Held by Institutions

‪45.18%‬

Price stats

Beta

‪-501,440.84‬

50-Day Avg

‪0.4978‬

200-Day Avg

‪2.27‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

6 analysts

Average price target

‪$ 2.20‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - MDXH - MdxHealth SA

Peers - MDXH - MdxHealth SA

Peer Comparison

Compared with companies in Diagnostics & Research listed on NASDAQ.

Profile Summary - MDXH - MdxHealth SA

About

MdxHealth SA is a pioneering biotechnology company specializing in molecular diagnostics. The company's primary function is to improve patient outcomes by offering innovative diagnostic solutions for the early detection of cancer. MdxHealth's non-invasive tests aid in the accurate diagnosis and management of cancers,…

SectorHealthcare
IndustryDiagnostics & Research
Employees364
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.